Metraipolis › archive › dc_ec982e087402
Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma — Europe PMC PMID:42972022
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42972022
- DOI
- 10.1038/s43856-[numero omesso]-1
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T12:42:27.169Z
- SHA-256 of the archived text
c83489d6f7eff42f886e3f3f0c801e1c9fe99e9a85973803ce1505f00fe68edc- Stable URL of this page
https://metraipolis.com/documento/dc_ec982e087402
How to cite
Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma — Europe PMC PMID:42972022 — Europe PMC (en), https://europepmc.org/article/MED/42972022 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec982e087402 (Metraipolis archive dc_ec982e087402, sha256 c83489d6f7eff42f886e3f3f0c801e1c9fe99e9a85973803ce1505f00fe68edc)
BibTeX
@misc{dcec982e087402,
title = {Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma — Europe PMC PMID:42972022},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42972022},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec982e087402; sha256 c83489d6f7eff42f886e3f3f0c801e1c9fe99e9a85973803ce1505f00fe68edc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42972022. Agents can read the archived copy with the MCP tool read_document.